Association Between Euploid Embryo Grade and Maternal Age
Launched by INCEPTION FERTILITY RESEARCH INSTITUTE, LLC · Jun 6, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Objective: To study if there is an association between advanced maternal age and lower embryo grading of euploid embryos.
Hypothesis: Advanced maternal age is associated with a lower embryonic grade in euploid embryos.
Study Design: This is a retrospective cross-sectional study of euploid embryos from patients who have completed IVF with PGT-A testing at a fertility clinic in The Prelude Network (US sites only). A comparison of embryo grade between different age groups (\<35, 40+) will be done after controlling for baseline demographic characteristics.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who have completed IVF egg retrieval with PGT-A testing at a fertility clinic in The Prelude Network (US clinics, excluding NYU)
- • PGT biopsy was conducted in 2023,
- • PGT biopsy was performed on blastocyst stage embryo,
- • PGT-A result is euploid.
- Exclusion Criteria:
- • PGT-A result is mosaic,
- • Embryos in which PGT-M was done and were found to be carriers of the mutation,
- • Embryos in which PGT-SR was done and were found to be carriers of the structural rearrangement.
About Inception Fertility Research Institute, Llc
Inception Fertility Research Institute, LLC, is a leading clinical research organization dedicated to advancing reproductive health through innovative research and evidence-based practices. With a commitment to improving outcomes in fertility treatments, the institute conducts rigorous clinical trials that explore new therapies and technologies in reproductive medicine. By collaborating with top-tier medical professionals and leveraging cutting-edge methodologies, Inception Fertility Research Institute aims to enhance the understanding of fertility challenges and contribute to the development of effective solutions for individuals and couples seeking to build families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported